EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐Cell Profiling and Proteomics‐Based Insights Into mTORC1 ‐Mediated Angio+ TAMs Polarization in Recurrent IDH ‐Mutant Gliomas

Xu Wang, Jingyan Gu, Hongyu Tang, Lianping Gu, Yunke Bi iD, Yue Kong, Qiao Shan, Jian Yin, Meiqing Lou iD, Shouwei Li, Yaohua Liu iD

CNS Neuroscience & Therapeutics · 2025

DOI: 10.1111/cns.70371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Xu Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Shanghai General Hospital, Shanghai, China. Hauptthemen laut MEDLINE: Glioma, Mechanistic Target of Rapamycin Complex 1, Isocitrate Dehydrogenase, Brain Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Songjiang District Science and Technology Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

IDH mutant gliomas often exhibit recurrence and progression, with the mTORC1 pathway and tumor‐associated macrophages potentially contributing to these processes. However, the precise mechanisms are not fully understood. This study seeks to investigate these relationships using proteomic, phosphoproteomic, and multi‐dimensional transcriptomic approaches.

Methods

This study established a matched transcriptomic, proteomic, and phosphoproteomic cohort of IDH‐mutant gliomas with recurrence and progression, incorporating multiple glioma‐related datasets. We first identified the genomic landscape of recurrent IDH‐mutant gliomas through multi‐dimensional differential enrichment, GSVA, and deconvolution analyses. Next, we explored tumor‐associated macrophage subpopulations using single‐cell sequencing in mouse models of IDH‐mutant and wild‐type gliomas, analyzing transcriptional changes via AddmodelScore and pseudotime analysis. We then identified these subpopulations in matched primary and recurrent IDH‐mutant datasets, investigating their interactions with the tumor microenvironment and performing deconvolution to explore their contribution to glioma progression. Finally, spatial transcriptomics was used to map these subpopulations to glioma tissue sections, revealing spatial co‐localization with mTORC1 and angiogenesis‐related pathways.

Results

Multi‐dimensional differential enrichment, GSVA, and deconvolution analyses indicated that the mTORC1 pathway and the proportion of M2 macrophages are upregulated during the recurrence and progression of IDH‐mutant gliomas. CGGA database analysis showed that mTORC1 activity is significantly higher in recurrent IDH‐mutant gliomas compared to IDH‐wildtype, with a correlation to M2 macrophage infiltration. KSEA revealed that AURKA is enriched during progression, and its inhibition reduces mTORC1 pathway activity. Single‐cell sequencing in mouse models identified a distinct glioma subpopulation with upregulated mTORC1, exhibiting both M2 macrophage and angiogenesis transcriptional features, which increased after implantation of IDH‐mutant tumor cells. Similarly, human glioma single‐cell data revealed the same subpopulation, with cell–cell communication analysis showing active VEGF signaling. Finally, spatial transcriptomics deconvolution confirmed the co‐localization of this subpopulation with mTORC1 and VEGFA in high‐grade IDH‐mutant gliomas.

Conclusions

Our findings suggest mTORC1 activation and Angio‐TAMs play key roles in the recurrence and progression of IDH‐mutant gliomas.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaMechanistic Target of Rapamycin Complex 1Isocitrate DehydrogenaseBrain NeoplasmsTumor-Associated MacrophagesAnimalsHumansMiceProteomicsMutationSingle-Cell AnalysisNeoplasm Recurrence, LocalTumor MicroenvironmentFemaleMale

Stichwörter der Autor:innen

IDH‐mutant gliomasmTORC1 pathwayphosphoproteomicsproteomicssingle‐cell sequencingspatial transcriptomicstumor‐associated macrophages

Substanzen

Mechanistic Target of Rapamycin Complex 1Isocitrate Dehydrogenase

Autor:innen und Institutionen

  • Department of Neurosurgery, Shanghai General Hospital, Shanghai, China.
  • Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Nanjing Medical University, Jiangsu, China.
  • Sun Yat-Sen University Guanghua School of Stomatology, Guangzhou, China.
  • Department of Neurosurgery, Capital Medical University Sanbo Brain Hospital, Beijing, China.

ORCID-Profile: Yunke Bi, Meiqing Lou, Yaohua Liu

Förderung

  • National Natural Science Foundation of China
  • Songjiang District Science and Technology Research Project

Zitieren

APA

Wang, X., Gu, J., Tang, H., Gu, L., Bi, Y., Kong, Y., Shan, Q., Yin, J., Lou, M., Li, S., & Liu, Y. (2025). Single‐Cell Profiling and Proteomics‐Based Insights Into mTORC1 ‐Mediated Angio+ TAMs Polarization in Recurrent IDH ‐Mutant Gliomas. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70371

Vancouver

Wang X, Gu J, Tang H, Gu L, Bi Y, Kong Y, et al. Single‐Cell Profiling and Proteomics‐Based Insights Into mTORC1 ‐Mediated Angio+ TAMs Polarization in Recurrent IDH ‐Mutant Gliomas. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70371

BibTeX
@article{Wang2025,
  author = {Wang, Xu and Gu, Jingyan and Tang, Hongyu and Gu, Lianping and Bi, Yunke and Kong, Yue and Shan, Qiao and Yin, Jian and Lou, Meiqing and Li, Shouwei and Liu, Yaohua},
  title = {Single‐Cell Profiling and Proteomics‐Based Insights Into mTORC1 ‐Mediated Angio+ TAMs Polarization in Recurrent IDH ‐Mutant Gliomas},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  doi = {10.1111/cns.70371}
}
Kostenlos starten →